Cabot (NYSE:CBT – Get Free Report) will post its quarterly earnings results after the market closes on Monday, November 4th. Analysts expect Cabot to post earnings of $1.82 per share for the quarter. Cabot has set its FY24 guidance at $7.00-$7.10 EPS.Persons interested in listening to the company’s earnings conference call can do so using this link.
Cabot (NYSE:CBT – Get Free Report) last posted its quarterly earnings results on Monday, August 5th. The specialty chemicals company reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.72 by $0.20. The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1 billion. Cabot had a net margin of 12.05% and a return on equity of 26.99%. The firm’s quarterly revenue was up 5.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.42 earnings per share. On average, analysts expect Cabot to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.
Cabot Trading Up 1.1 %
CBT opened at $109.02 on Friday. The stock has a market capitalization of $5.98 billion, a PE ratio of 12.96, a P/E/G ratio of 0.92 and a beta of 1.19. The firm’s fifty day moving average price is $108.20 and its 200 day moving average price is $100.75. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.22 and a quick ratio of 1.45. Cabot has a 12-month low of $65.93 and a 12-month high of $117.14.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Report on CBT
Insider Transactions at Cabot
In other news, CEO Sean D. Keohane sold 25,617 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the completion of the transaction, the chief executive officer now owns 331,174 shares in the company, valued at approximately $33,630,719.70. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Sean D. Keohane sold 25,617 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total value of $2,601,406.35. Following the completion of the transaction, the chief executive officer now owns 331,174 shares in the company, valued at $33,630,719.70. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Erica Mclaughlin sold 23,274 shares of the stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total transaction of $2,322,512.46. Following the completion of the transaction, the chief financial officer now owns 59,814 shares of the company’s stock, valued at $5,968,839.06. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 71,939 shares of company stock worth $7,308,812. Insiders own 3.07% of the company’s stock.
About Cabot
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Articles
- Five stocks we like better than Cabot
- How to Plot Fibonacci Price Inflection Levels
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Stock Sentiment Analysis: How it Works
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.